GEODE CAPITAL MANAGEMENT, LLC

Holdings History for NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (NAMS)

Symbol: NAMS on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value EUR0.12 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$3,590,016	102,395	+437	+0.43%	$35.06	Q4 2025
30 Sep 2025	0%	+0%	$2,897,982	101,958	+2,501	+2.5%	$28.42	Q3 2025
30 Jun 2025	0%	+0%	$1,800,039	99,457	+13,629	+16%	$18.10	Q2 2025
31 Mar 2025	0%	-0%	$1,756,848	85,828	-2,716		$20.47	Q1 2025
31 Dec 2024	0%	+0%	$2,275,580	88,544	+2,222	+2.6%	$25.70	Q4 2024
30 Sep 2024	0%	+0%	$1,432,945	86,322	+1,399	+1.6%	$16.60	Q3 2024
30 Jun 2024	0%	+0%	$1,631,370	84,923	+32,738	+63%	$19.21	Q2 2024
31 Mar 2024	0%	+0%	$1,234,175	52,185	+4,861	+10%	$23.65	Q1 2024
31 Dec 2023	0%	+0%	$528,609	47,324	+5,516	+13%	$11.17	Q4 2023
30 Sep 2023	0%	+0%	$386,724	41,808	+16,040	+62%	$9.25	Q3 2023
30 Jun 2023	0%	+0%	$306,381	25,768	+7,209	+39%	$11.89	Q2 2023
31 Mar 2023	0%	+0%	$249,432	18,559	+18,559	NEW	$13.44	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.